Economic Evaluation in Cardiology: Remote Monitoring of Pacemakers
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02234245|
Recruitment Status : Completed
First Posted : September 9, 2014
Last Update Posted : October 16, 2018
The purpose of this research is to estimate the outcomes in health and cost of the follow-up of patients with pacemakers.
The initial hypothesize of this study is that remote monitoring of pacemaker will show a best relation of outcomes in costs and effectiveness than the conventional follow-up in hospital.
|Condition or disease||Intervention/treatment||Phase|
|Cardiovascular Disease||Device: Telemedicine System||Not Applicable|
Cardiovascular Diseases are a major cause of global morbidity and mortality, being responsible according to the World Health Organization of the 30% of overall mortality.
Since 2001 that the first pacemaker of remote monitoring was implanted in Europe, more than 300,000 pacemaker have been implanted around the world. Despite this sharp expansion, the scientific evidence on economic evaluations of pacemaker with remote monitoring is very limited, and in our knowledge, studies including informal costs have not been conducted.
In the field of cardiology, telemedicine allows consultations with patients through monitoring systems and remote communication analyzing the ongoing heart rates of people with pacemakers, implantable cardioverter defibrillators, cardiac resynchronization therapy and subcutaneous Holter. The use of remote monitoring may save time and efforts to both healthcare professionals and patients, including their informal caregivers, reducing the number of follow up visits to the hospital and reducing the associated costs with patient follow-up, which will help to improve sustainability of healthcare services.
During the 12 months of study, the patients with implant of pacemakers of both groups will be assessed of the same parameters, in 4 different moments (pre-implant and months 1, 6, 12 and 5 years post-implantation).
The study will estimate: 1) The Clinical features of the patients. 2) The effectiveness through of administration of health-related quality of life, functional capacity questionnaires and 3) Finally, the hospital and informal costs of patients with pacemakers will be estimated by the researches.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||83 participants|
|Intervention Model:||Parallel Assignment|
|Primary Purpose:||Health Services Research|
|Official Title:||Economic Evaluation in Cardiology: Remote Monitoring of Pacemakers|
|Study Start Date :||October 2012|
|Actual Primary Completion Date :||November 2013|
|Actual Study Completion Date :||October 2018|
No Intervention: Hospital monitoring of pacemakers
Patients have to go to the hospital to be monitorized
Experimental: Remote monitoring of pacemakers
Patients have not to go to the hospital to be monitorized
Device: Telemedicine System
Telemedicine System is used in remote monitoring group
Other Name: Patients are monitorized from hospital
- Clinical features [ Time Frame: 12 months ]
Selected variables from the medical history records:
- indication for the implantation of the pacemaker.
- pharmacological treatment
- vital signs
- pacemaker parameters
- Health-Related Quality of Life [ Time Frame: 5 years ]EuroQol-5Dimensions (EQ-5D)
- Functional capacity [ Time Frame: 5 years ]Duke Activity Status Index (DASI).
- Direct costs [ Time Frame: 5 years ]
Direct costs taken into account:
- pacemakers' costs´(device implanted)
- hospitalizations' costs
- consultations' costs (hospital)
- prescribed medical transport's cost
- health personnel costs
- pharmaceutical costs
- Indirect cost [ Time Frame: 5 years ]
Maintenance of the medical consultation (hospital):
- Health fungible
- equipment investment
- Informal costs [ Time Frame: 5 years ]
Costs related to the care and displacements of patients to hospital:
- displacement costs to hospital
- Accommodation costs
- Cost of meals
- Costs for caregivers
- Number of patients with Adverse Events [ Time Frame: 5 years ]
Number of patients with Adverse Events
- type of Adverse Events diagnosed
- Consultations and Hospitalizations unscheduled [ Time Frame: 5 years ]- number of unscheduled visits and hospitalizations
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02234245
|Hospital de Poniente|
|El Ejido, Almeria, Spain, 04700|